Activation of the interleukin-6 promoter by a dominant negative mutant of c-Jun

被引:49
作者
Faggioli, L [1 ]
Costanzo, C [1 ]
Donadelli, M [1 ]
Palmieri, M [1 ]
机构
[1] Univ Verona, Dept Neurol & Vis Sci, Biochem Sect, I-37134 Verona, Italy
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 2004年 / 1692卷 / 01期
关键词
interleukin-6; transcription; Transfection; NF-kappa B; C/EBP; AP-1;
D O I
10.1016/j.bbamcr.2004.03.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The human IL-6 promoter contains multiple regulatory elements such as those binding transcription factors belonging to the NF-kappaB (-75/-63), C/EBP (-158/ -145 and -87/-76) and AP-1 (-283/-277) families. Herein, we report that ectopic expression of c-Jun, C/EBP6, and the p65 subunit of NF-kappaB synergistically activates an IL-6 promoter construct containing only a TATA box and a kappaB binding site. These results suggest that interactions among NF-kappaB, C/EBP, and AP-1, which are all activated by the most powerful physiological inducers of the IL-6 gene, namely TNF-alpha and IL-1, may be crucial for maximal activation of the IL-6 promoter in response to the two cytokines. Furthermore, we show that a mutated form of c-Jun lacking the transactivation domain (TAM-67) was a much stronger activator of the IL-6 promoter than c-Jun. In combination with p65 and/or C/EBP6, TAM-67 also synergistically activated the IL-6 promoter, while it inhibited TNF-alpha induced AP-1 activity directing an AP-1-responsive reporter plasmid. Lastly, electrophoretic mobility shift assay (EMSA) results strongly suggest the formation of complexes between p65, C/EBP6, and/or c-Jun or TAM-67 on the kappaB site, supporting the idea that the functional synergism is determined by a physical interaction. These data provide new insight into the molecular mechanisms regulating the formation of the transcription complex responsible for IL-6 promoter activation. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:17 / 24
页数:8
相关论文
共 32 条
[1]   INTERLEUKIN-6 IN BIOLOGY AND MEDICINE [J].
AKIRA, S ;
TAGA, T ;
KISHIMOTO, T .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :1-78
[2]   NF-IL6 and NF-κB in cytokine gene regulation [J].
Akira, S ;
Kishimoto, T .
ADVANCES IN IMMUNOLOGY, VOL 65, 1997, 65 :1-46
[3]   A NUCLEAR FACTOR FOR IL-6 EXPRESSION (NF-IL6) IS A MEMBER OF A C/EBP FAMILY [J].
AKIRA, S ;
ISSHIKI, H ;
SUGITA, T ;
TANABE, O ;
KINOSHITA, S ;
NISHIO, Y ;
NAKAJIMA, T ;
HIRANO, T ;
KISHIMOTO, T .
EMBO JOURNAL, 1990, 9 (06) :1897-1906
[4]   THE ROLE OF JUN, FOS AND THE AP-1 COMPLEX IN CELL-PROLIFERATION AND TRANSFORMATION [J].
ANGEL, P ;
KARIN, M .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1072 (2-3) :129-157
[5]   Interleukin-6 repression is associated with a distinctive chromatin structure of the gene [J].
Armenante, F ;
Merola, M ;
Furia, A ;
Tovey, M ;
Palmieri, M .
NUCLEIC ACIDS RESEARCH, 1999, 27 (22) :4483-4490
[6]  
BROWN PH, 1994, ONCOGENE, V9, P791
[7]   Dynamic shuttling of nuclear factor κB between the nucleus and cytoplasm as a consequence of inhibitor dissociation [J].
Carlotti, F ;
Dower, SK ;
Qwarnstrom, EE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41028-41034
[8]   Functional interaction between c-Jun and promoter factor Sp1 in epidermal growth factor-induced gene expression of human 12(S)-lipoxygenase [J].
Chen, BK ;
Chang, WC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (19) :10406-10411
[9]   MULTIPLE REGULATORY ELEMENTS IN THE INTERLEUKIN-6 GENE MEDIATE INDUCTION BY PROSTAGLANDINS, CYCLIC-AMP, AND LIPOPOLYSACCHARIDE [J].
DENDORFER, U ;
OETTGEN, P ;
LIBERMANN, TA .
MOLECULAR AND CELLULAR BIOLOGY, 1994, 14 (07) :4443-4454
[10]   Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty [J].
Ershler, WB ;
Keller, ET .
ANNUAL REVIEW OF MEDICINE, 2000, 51 :245-270